Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Hospital Readmission After Vulvar Cancer Surgery

Gynecol Oncol; ePub 2016 Nov 8; Dorney, et al

Readmission after surgery for vulvar cancer can lead to lengthy hospitalization and reoperation, with discharge to a post-acute care facility (PACF) associated with risk of readmission, a recent study found. The study included 363 patients with squamous cell carcinoma in situ (35.6%) or invasive cancer (64.5%) who underwent vulvectomy between January 2001 and June 2014. Researchers found:

  • Radical vulvectomy was performed in 39.1% of patients and 23.4% underwent lymph node assessment.
  • 17 patients (4.7%) were readmitted within 30 days (length of stay 2 to 37 days); 35% required a reoperation.
  • On multivariate analysis, only discharge to a PACF was significantly associated with readmission (OR, 6.30).
  • 29.4% of patients readmitted within 30 days had been at a PACF; whereas only 6.6% of the no readmission group had been discharged to PACF.


Dorney KM, Growdon WB, Clemmer J, et al. Patient, treatment and discharge factors associated with hospital readmission within 30 days after surgery for vulvar cancer. [Published online ahead of print November 8, 2016]. Gynecol Oncol. doi:10.1016/j.ygyno.2016.11.009.